References
- SchuchatAGroup B StreptococcusLancet1999353 51 5610.1016/S0140-6736(98)07128-1
- BakerCJBarrettFFTransmission of group B streptococci among parturient women and their neonatesJ. Pediatr.19738391992510.1016/S0022-3476(73)80524-4
- BakerCJBarrettFFGroup B streptococcal infections in infants. The importance of the various serotypesJAMA19742301158116010.1001/jama.1974.03240080040025
- BerardiAGroup B streptococcus late-onset disease: 2003-2010Pediatrics2013131e361e36810.1542/peds.2012-1231
- CampbellJRGroup B streptococcal colonization and serotype-specific immunity in pregnant women at deliveryObstet. Gynecol.200096498503
- EdmondKMGroup B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysisLancet201237954755610.1016/S0140-6736(11)61651-6
- FranciosiRAKnostmanJDZimmermanRAGroup B streptococcal neonatal and infant infectionsJ. Pediatr.19738270771810.1016/S0022-3476(73)80604-3
- TapsallJWPhillipsEAPresumptive identification of Group B streptococci by rapid detection of CAMP factor and pigment productionDiagn. Microbiol. Infect. Dis.1987722522810.1016/0732-8893(87)90010-1
- RamaswamySVIdentification of novel cps locus polymorphisms in nontypable Group B streptococcusJ. Med. Microbiol.20065577578310.1099/jmm.0.46253-0
- DoranKSNizetVMolecular pathogenesis of neonatal Group B streptococcal infection: no longer in its infancyMol. Microbiol.200454233110.1111/j.1365-2958.2004.04266.x
- HerbertMABeveridgeCJSaundersNJBacterial virulence factors in neonatal sepsis: Group B streptococcusCurr. Opin. Infect. Dis.20041722522910.1097/00001432-200406000-00009
- RubensCEWesselsMRKuypersJMKasperDLWeiserJNMolecular analysis of the two Group B streptococcal virulence factorsSemin. Perinatol.1990142229
- SlotvedHCKongFLambertsenLSauerSGilbertGLSerotype IX, a proposed new streptococcus agalactiae serotypeJ. Clin. Microbiol.2007452929293610.1128/JCM.00117-072045254
- AfsharBInternational quality assurance for laboratory identification and typing of Streptococcus agalactiae (Group B streptococci)J. Clin. Microbiol.2011491475148210.1128/JCM.02365-103122801
- XiaFDCapsular polysaccharide of Group B streptococcus mediates biofilm formation in the presence of human plasmaMicrobes Infect.201517717610.1016/j.micinf.2014.10.007
- HarrisonLHSerotype distribution of invasive Group B streptococcal isolates in Maryland: implications for vaccine formulationJ. Infect. Dis.1998177998100210.1086/515260
- ChaffinDOMenteleLMRubensCESialylation of Group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expressionJ. Bacteriol.20051874615462510.1128/JB.187.13.4615-4626.20051151781
- WesselsMRHaftRFHeggenLMRubensCEIdentification of a genetic locus essential for capsule sialylation in type III group B streptococciInfect. Immun.199260392400257641
- BertiFStructure of the type IX group B streptococcus capsular polysaccharide and its evolutionary relationship with types V and VIIJ. Biol. Chem.2014289234372344810.1074/jbc.M114.5679744156066
- CieslewiczMJStructural and genetic diversity of Group B streptococcus capsular polysaccharidesInfect. Immun.2005733096310310.1128/IAI.73.5.3096-3103.20051087335
- CarlinAFGroup B streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5J. Exp. Med.20092061691169910.1084/jem.200906912722167
- MarquesMBKasperDLPangburnMKWesselsMRPrevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III Group B streptococciInfect. Immun.19926039863993257427
- AlhhazmiAPandeyATyrrellGJidentification of the Group B streptococcus capsule type using a dual phenotypic/genotypic assayJ. Clin. Microbiol.2017552637265010.1128/JCM.00300-175648701
- Di PaloBAdaptive response of Group B streptococcus to high glucose conditions: new insights on the CovRS regulation networkPLoS ONE20138e6129410.1371/journal.pone.00612943621830
- LamyMCCovS/CovR of Group B streptococcus: a two-component global regulatory system involved in virulenceMol. Microbiol.2004541250126810.1111/j.1365-2958.2004.04365.x
- LupoARuppenCHemphillASpellerbergBSendiPPhenotypic and molecular characterization of hyperpigmented Group B StreptococciInt. J. Med. Microbiol.201430471772410.1016/j.ijmm.2014.05.003
- SendiPBacterial phenotype variants in Group B Streptococcal toxic shock syndromeEmerg. Infect. Dis.20091522323210.3201/eid1502.0809902657631
- Whidbey, C. et al. A hyperhaemolytic/hyperpigmented Group B streptococcus strain with a CovR mutations isolated from an adolescent patient with sore throat. Clin. Res. Infect. Dis.2, 1018 (2015).
- WhidbeyCA hemolytic pigment of Group B streptococcus allows bacterial penetration of human placentaJ. Exp. Med.20132101265128110.1084/jem.201227533674703
- LiuGYSword and shield: linked Group B streptococcal beta-hemolysin/cytolysin and carentoid pigment function to subvert host phagocyte defenseProc. Natl Acad. Sci. USA2004101144911449610.1073/pnas.0406143101
- AlhhazmiAHurteauDTyrrellGJEpidemiology of invasive Group B streptococcal disease in Alberta, Canada 2003-2013J. Clin. Microbiol.2016541774178110.1128/JCM.00355-164922093
- KeDDevelopment of conventional and real-time PCR assays for the rapid detection of Group B streptococciClin. Chem.200046324331
- CieslewiczMJKasperDLWangYWesselsMRFunctional analysis in the type Ia Group B streptococcus cluster of genes involved in extracellular polysaccharide production by diverse species of streptococciJ. Biol. Chem.200127613914610.1074/jbc.M005702200
- D’UrzoNAcidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strainsAppl. Environ. Microbiol.2014802176218510.1128/AEM.03627-133993151
- ParkerREAssociation between genotypic diversity and biofilm production in Group B streptococcusBMC Microbiol.2016168610.1186/s12866-016-0704-94875601
- RosiniRMargaritIBiofilm formation by Streptococcus agalactiae: influence of environmental conditions and implicated virulence factorsFront. Cell. Infect. Microbiol.201546
- NeemuchwalaATeateroSAtheyTBMcGeerAFittipaldiNCapsular switching and other large-scale recombination events in invasive sequence Type 1 group B streptococcusEmerg. Infect. Dis.2016221941194410.3201//eid2211.1520645088006
- PoyartCMultiplex PCR assay for rapid and accurate capsular typing of Group B streptococciJ. Clin. Microbiol.2007451985198810.1128/JCM.00159-071933079
- TettlinHComplete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiaeProc. Natl Acad. Sci. USA200299123911239610.1073/pnas.182380799
- WhidbeyCA hyperhemolytic/hyperpigmented Group B streptococcus strain with a CovR mutation isolated from an adolescent patient with a sore throatClin. Res. Infect. Dis.2015210184762654
- AlmeidaAParallel evolution of group B streptococcus hypervirulent clonal complex 17 unveils new pathoadaptive mutationsmSystems20172e000741710.1128/mSystems.00074-175585690
- KapataiGPatelDEfstratiouAChalkerVJComparison of molecular serotyping approaches of Streptococcus agalactiae from genomic sequencesBMC Genomics20171810.1186/s12864-017-3820-55455115
- OverbeekRThe SEED and the rapid annotation of microbial genomes using subsystems technology (RAST)Nucleic Acids Res.201442D206D21410.1093/nar/gkt1226
- JonesNMultilocus sequence typing system for Group B streptococcusJ. Clin. Microbiol.2003412530253610.1128/JCM.41.6.2530-2536.2003156480
- FeilEJLiBCAanensenDMHanageWPSprattBGeBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing dataJ. Bacteriol.20041861518153010.1128/JB.186.5.1518-1530.2004344416
- SprattBJHanageWPAanensenDMFeilEJDisplaying the relatedness among isolates of bacterial species – the eBURST approachFEMS Microbiol. Lett.200424112913410.1016/j.femsle.2004.11.015
- JohnsonDRFerrieriPGroup B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypesJ. Clin. Microbiol.198419506510271105
- LancefieldRCMcCartyMEverlyWNMultiple mouse-protective antibodies directed against Group B streptococci. Special reference to antibodies effective against protein antigensJ. Exp. Med.197514216517910.1084/jem.142.1.165
- BellaisSCapsular switching in Group B streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine developmentJ. Infect. Dis.20122061745175210.1093/infdis/jis605
- RubensCEHeggenLMHaftRFWesselsMRIdentification of cpsD, a gene essential for type III capsule expression in Group B streptococciMol. Microbiol.1993884385510.1111/j.1365-2958.1993.tb01631.x
- RubensCEWesselsMRHeggenLMKasperDLTransposon mutagenesis of type III Group B streptococcus: correlation of capsule expression with virulenceProc. Natl Acad. Sci. USA1987847208721210.1073/pnas.84.20.7208
- TyrrellGJKennedyAShokoplesSESherburneRKBinding and invasion of HeLa and MRC-5 cells by Streptococcus agalactiaeMicrobiology20021483921393110.1099/00221287-148-12-3921
- JiangSMCieslewiczMJKasperDLWesselsMRRegulation of virulence by a two-component system in Group B streptococcusJ. Bacteriol.20051871105111310.1128/JB.187.3.1105-1113.2005545708